Oxidant and antioxidant status in neonatal proven and clinical sepsis according to selenium status

Pediatrics International

Volumn 57, Issue 6, 2015, Pages 1131-1137

  Asci, Ali ^a,b   Surmeli Onay, Ozge ^a   Erkekoglu, Pinar ^a   Yigit, Sule ^a   Yurdakok, Murat ^a   Kocer Gumusel, Belma ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

antioxidant enzyme; clinical sepsis; oxidative stress; proven sepsis; selenium; selenoenzyme

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 2; INTERLEUKIN 6; PROCALCITONIN; SELENIUM; SELENOPROTEIN; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE; ANTIOXIDANT; OXIDIZING AGENT;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; LIPID PEROXIDATION; NEWBORN; NEWBORN ASSESSMENT; NEWBORN SEPSIS; NUTRITIONAL STATUS; OXIDATION KINETICS; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; BLOOD; FEMALE; FOLLOW UP; MALE; METABOLISM; RETROSPECTIVE STUDY; TIME FACTOR;

ANTIOXIDANTS; BIOMARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; LIPID PEROXIDATION; MALE; NEONATAL SEPSIS; OXIDANTS; OXIDATIVE STRESS; RETROSPECTIVE STUDIES; SELENIUM; TIME FACTORS;

EID: 84983212543     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12698     Document Type: Article

References (41)

1. Arnon S, Litmanovitz I,. Diagnostic tests in neonatal sepsis. Curr. Opin. Infect. Dis. 2008; 21: 223-27.
2. Schaffner J, Chochua S, Kourbatova EV,. High mortality among patients with positive blood cultures at a children's hospital in Tbilisi, Georgia. J. Infect. Dev. Ctries. 2009; 3: 267-72.
3. Zakariya BP, Bhat BV, Harish BN, Arun Babu T, Joseph NM,. Risk factors and predictors of mortality in culture proven neonatal sepsis. Indian J. Pediatr. 2012; 79: 358-61.
4. Bauer K, Zemlin M, Hummel M, et al,. Diversification of Ig heavy chain genes in human preterm neonates prematurely exposed to environmental antigens. J. Immunol. 2002; 169: 1349-56.
5. Mannan MA, Jahan N, Dey SK, Uddin MF, Ahmed S,. Maternal and foetal risk factor and complication with immediate outcome during hospital stay of very low birth weight babies. Mymensingh Med. J. 2012; 21: 639-47.
6. Scrimshaw NS,. Nutrition and infection. Prog. Food Nutr. Sci. 1975; 1: 393-420.
7. Beck MA, Levander OA, Handy J,. Selenium deficiency and viral infection. J. Nutr. 2003; 133: 1463S-7S.
8. Arthur JR, McKenzie RC, Beckett GJ,. Selenium in the immune system. J. Nutr. 2003; 133: 1457S-79S.
9. Avissar N, Whitin JC, Allen PZ, Wagner DD, Liegey P, Cohen HJ,. Plasma selenium-dependent glutathione peroxidase. Cell of origin and secretion. J. Biol. Chem. 1989; 264: 15850-55.
10. Björnstedt M, Kumar S, Björkhem L, Spyrou G, Holmgren A,. Selenium and the thioredoxin and glutaredoxin systems. Biomed. Environ. Sci. 1997; 10: 271-9.
11. Watson WH, Yang X, Choi YE, Jones DP, Kehrer JP,. Thioredoxin and its role in toxicology. Toxicol. Sci. 2004; 78: 3-14.
12. Forceville X, Mostert V, Pierantoni A, et al,. Selenoprotein P, rather than glutathione peroxidase, as a potential marker of septic shock and related syndromes. Eur. Surg. Res. 2009; 43: 338-47.
13. Lü JM, Lin PH, Yao Q, Chen C,. Chemical and molecular mechanisms of antioxidants: Experimental approaches and model systems. J. Cell. Mol. Med. 2010; 14: 840-60.
14. Catalá A,. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem. Phys. Lipids 2009; 157: 1-11.
15. Satar M, Özlü F,. Neonatal sepsis: A continuing disease burden. Turk. J. Pediatr. 2012; 54: 445-9.
16. Flohé L, Günzler WA,. Assays of glutathione peroxidase. Methods Enzymol. 1984; 105: 114-21.
17. Arnér ES, Zhong L, Holmgren A,. Preparation and assay of mammalian thioredoxin and thioredoxin reductase. Methods Enzymol. 1999; 300: 226-39.
18. Kirkbright GE,. Atomic absorption spectroscopy. In: Elemental Analysis of Biological Materials. Vienna Technical Report Series 197. International Atomic Agency, Vienna, 1980; 141-65.
19. Aebi H,. Catalase. In:, Bergmeyer HU, (ed). Methods of Enzymatic Analysis. Academic Press, New York, 1974; 673-7.
20. Marklund S, Marklund G,. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 1974; 47: 469-74.
21. Akerboom TP, Sies H,. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol. 1981; 77: 373-82.
22. Richard MJ, Portal B, Meo J, Coudray C, Hadjian A, Favier A,. Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin. Chem. 1992; 38: 704-9.
23. Anderson-Berry AL, Bellig LL, Ohning BL,. Neonatal sepsis. e-Medicine (serial online). Published 14 February 2014. (Accessed 25 July 2014.) Available from URL: http://emedicine.medscape.com/article/978352-overview
24. Pepys MB, Hirschfield GM,. C-reactive protein: A critical update. J. Clin. Invest. 2003; 111: 1805-12.
25. Grant SS, Hung DT,. Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response. Virulence 2013; 4: 273-83.
26. Zahrt TC, Deretic V,. Reactive nitrogen and oxygen intermediates and bacterial defenses: Unusual adaptations in Mycobacterium tuberculosis. Antioxid. Redox Signal. 2002; 4: 141-59.
27. Motoyama T, Okamoto K, Kukita I, Hamaguchi M, Kinoshita Y, Ogawa H,. Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit. Care Med. 2003; 31: 1048-52.
28. Macdonald J, Galley HF, Webster NR,. Oxidative stress and gene expression in sepsis. Br. J. Anaesth. 2003; 90: 221-32.
29. Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR,. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit. Care Med. 1995; 23: 646-51.
30. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK,. Plasma antioxidant potential in severe sepsis: A comparison of survivors and nonsurvivors. Crit. Care Med. 1996; 24: 1179-83.
31. Forceville X, Vitoux D, Gauzit R, Combes A, Lahilaire P, Chappuis P,. Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit. Care Med. 1998; 26: 1536-1544.
32. Sakr Y, Reinhart K, Bloos F, et al,. Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure. Br. J. Anaesth. 2007; 98: 775-784.
33. Fairweather-Tait SJ, Bao Y, Broadley MR, et al,. Selenium in human health and disease. Antioxid. Redox Signal. 2011; 14: 1337-83.
34. Erkekoʇlu P, Aşçi A, Ceyhan M, et al,. Selenium levels, selenoenzyme activities and oxidant/antioxidant parameters in H1N1-infected children. Turk. J. Pediatr. 2013; 55: 271-82.
35. Giray B, Hincal F, Teziç T, Okten A, Gedik Y,. Status of selenium and antioxidant enzymes of goitrous children is lower than healthy controls and nongoitrous children with high iodine deficiency. Biol. Trace Elem. Res. 2001; 82: 35-52.
36. Harrison I, Littlejohn D, Fell GS,. Distribution of selenium in human blood plasma and serum. Analyst 1996; 121: 189-94.
37. Barceloux DG,. Selenium. J. Toxicol. Clin. Toxicol. 1999; 37: 145-172.
38. Gao Y, Liu Y, Deng G, Wang Z,. Distribution of selenium-containing proteins in human serum. Biol. Trace Elem. Res. 2004; 100: 105-15.
39. Lehmann C, Egerer K, Weber M, et al,. Effect of selenium administration on various laboratory parameters of patients at risk for sepsis syndrome. Med. Klin. (Munich) 1997; 92S3: 14-16.
40. Forceville X, Laviolle B, Annane D, et al,. Effects of high doses of selenium, as sodium selenite, in septic shock: A placebo-controlled, randomized, double-blind, phase II study. Crit. Care 2007; 11: R73.
41. Zimmermann T, Albrecht S, Kühne H, et al,. Selenium administration in patients with sepsis syndrome. A prospective randomized study. Med. Klin. (Munich) 1997; 92S3: 3-4.